4//SEC Filing
HIPP RAYMOND R 4
Accession 0001077183-20-000213
CIK 0001077183other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 6:53 PM ET
Size
8.4 KB
Accession
0001077183-20-000213
Insider Transaction Report
Form 4
HIPP RAYMOND R
Director
Transactions
- Sale
Common Stock
2020-11-16$42.28/sh−70,000$2,959,600→ 66,800 total
Holdings
- 3,448
Stock Option (Right to Buy)
Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying) - 3,334
Stock Option (Right to Buy)
Exercise: $7.27Exp: 2022-05-25→ Common Stock (3,334 underlying) - 4,269
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying)
Footnotes (1)
- [F1]On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001188214
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 6:53 PM ET
- Size
- 8.4 KB